What is the new drug for parathyroid? Exploring Recent Innovations
•
4 min read
Hypoparathyroidism, a rare condition often caused by neck surgery, affects an estimated 70,000 people in the United States [1.7.1, 1.9.5]. So, what is the new drug for parathyroid that's changing patient care? The FDA recently approved Yorvipath (palopegteriparatide), a once-daily hormone replacement therapy [1.2.3, 1.3.1].
